Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.99 USD
Change Today +0.005 / 0.51%
Volume 25.4K
DYAI On Other Exchanges
Symbol
Exchange
OTC US
As of 5:20 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

dyadic international inc (DYAI) Snapshot

Open
$1.02
Previous Close
$0.98
Day High
$1.02
Day Low
$0.99
52 Week High
09/2/14 - $1.84
52 Week Low
12/11/14 - $0.80
Market Cap
33.5M
Average Volume 10 Days
65.6K
EPS TTM
$-0.08
Shares Outstanding
34.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DYADIC INTERNATIONAL INC (DYAI)

dyadic international inc (DYAI) Related Bloomberg News

View More Bloomberg News

dyadic international inc (DYAI) Related Businessweek News

No Related Businessweek News Found

dyadic international inc (DYAI) Details

Dyadic International, Inc., a biotechnology company, discovers, develops, manufactures, and sells enzymes and other proteins for the bioenergy, biochemical, biopharmaceutical, and industrial enzyme industries. It utilizes an integrated technology platform based on its patented and proprietary C1 microorganism, which enables the development and manufacture of enzymes and other proteins for various markets. The company licenses its patented and proprietary technologies; and provides research and development services for third parties. In addition, it manufactures and sells liquid and dry enzyme products for use in the animal feed, pulp and paper, starch and alcohol, food and brewing, textiles, and biofuels industries. The company’s C1 Platform Technology could also be used for developing and producing other biological products, such as antibodies, vaccines, proteins, and polypeptides for the biopharmaceutical industry. Dyadic International, Inc. has operations in the United States and the Netherlands. The company was founded in 1979 and is headquartered in Jupiter, Florida.

57 Employees
Last Reported Date: 03/11/15
Founded in 1979

dyadic international inc (DYAI) Top Compensated Officers

Chief Executive Officer, President, Founder, ...
Total Annual Compensation: $385.4K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $195.4K
Vice President of Operations
Total Annual Compensation: $225.0K
Compensation as of Fiscal Year 2013.

dyadic international inc (DYAI) Key Developments

Dyadic International, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Financial Guidance for the Fiscal 2016

Dyadic International, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported total Revenue was $3.832 million against $3.062 million a year ago. The increase in revenue for the period was driven by growth in the animal nutrition, initial sales of enzymes into biogas and food markets. Operating loss was $0.207 million against $1.516 million a year ago. Net loss was $0.423 million against $1.68 million a year ago. Basic and diluted net loss per common loss per share was $0.01 against $0.05 a year ago. For the six months, the company reported total Revenue was $7.87 million against $6.05 million a year ago. The increase in revenue for the period was driven by growth in the animal nutrition, initial sales of enzymes into the biogas industry, and food markets. Operating loss was $0.411 million against $2.93 million a year ago. Net loss was $0.804 million against $3.25 million a year ago. Basic and diluted net loss per common loss per share was $0.02 against $0.10 a year ago. The company anticipates that many of the application trials have ongoing in animal feed, baking, brewery, biogas and other industries, along with the expected continued improvements in science, should help the company to realize the business objectives in 2016 and beyond.

Dyadic International, Inc. to Report Q2, 2015 Results on Aug 17, 2015

Dyadic International, Inc. announced that they will report Q2, 2015 results at 5:00 PM, US Eastern Standard Time on Aug 17, 2015

Dyadic International, Inc., Q2 2015 Earnings Call, Aug 17, 2015

Dyadic International, Inc., Q2 2015 Earnings Call, Aug 17, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DYAI:US $0.99 USD +0.005

DYAI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
EI du Pont de Nemours & Co $51.50 USD -0.34
View Industry Companies
 

Industry Analysis

DYAI

Industry Average

Valuation DYAI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYADIC INTERNATIONAL INC, please visit www.dyadic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.